|
1) 厚生労働省健康局｢平成14年度糖尿病実態調査報告｣. Available from: URL http://www.mhlw.go.jp/shingi/2004/03/s0318-15.html Accessed at April 15, 2007
|
|
|
|
|
2) Booth GL, Kapral MK, Fung K, et al. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368: 29-36
|
|
|
|
|
3) Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus; The Framingham Heart Study. Circulation. 2007; 115: 1544-50
|
|
|
|
|
|
4) Haffner SM, Lehto S, Ronnemaa T, et al. Mor-tality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-34
|
|
|
|
|
|
5) Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Regis-try. Circulation. 2000; 102: 1014-9
|
|
|
|
|
|
6) Shindler DM, Palmeri ST, Antonelli TA, et al. Diabetes mellitus in cardiogenic shock compli-cating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000; 36: 1097-103
|
|
|
|
|
|
7) The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996; 335: 217-25
|
|
|
|
|
|
8) The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investi-gation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000; 35: 1122-9
|
|
|
|
|
|
9) The BARI Investigators. The final 10-year follow-up results from the BARI randomization trial. J Am Coll Cardiol. 2007; 49: 1600-6
|
|
|
|
|
|
10) Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical and percuta-neous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol. 2001; 37: 1008-15
|
|
|
|
|
|
11) Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM). Available from: URL http://www.clinicaltrials.gov/ct/show/NCT00086450？order Accessed at April 15, 2007
|
|
|
|
|
|
12) Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized controlled trials. BMJ. 2000; 321: 73-7
|
|
|
|
|
|
13) Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis. Circulation. 2005; 111: 2906-12
|
|
|
|
|
|
14) Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1506-16
|
|
|
|
|
|
15) Brophy JM, Belisle P, Joseph L, et al. Evidence for use of coronary stents. Ann Intern Med. 2003; 138: 777-86
|
|
|
|
|
|
16) Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of random-ized clinical trials of drug-eluting stents. Lancet. 2004; 364: 583-91
|
|
|
|
|
|
17) Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents: an updated meta-analysis of randomized controlled trials. Heart. 2006; 92: 641-9
|
|
|
|
|
|
18) Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006; 27: 2784-814
|
|
|
|
|
|
19) Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 1030-9
|
|
|
|
|
|
20) Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007; 356: 1009-19
|
|
|
|
|
|
21) Yusuf S, Zucker D, Peduzzi, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994; 344: 563-70
|
|
|
|
|
|
22) Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003; 41: 1293-304
|
|
|
|
|
|
23) The SoS investigators. Coronary artery bypass versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial. Lancet. 2002; 360: 965-70
|
|
|
|
|
|
24) Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol. 2005; 46: 575-81
|
|
|
|
|
|
25) Rodriguez AE, Baldi J, Pereira CF, et al. Five-year follow-up of the Argentine randomized trial of coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005; 46: 582-8
|
|
|
|
|
|
26) Hannan E, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005; 352: 2174-83
|
|
|
|
|
|
27) Ong ATL, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006; 151: 1194-204
|
|
|
|
|
|
28) Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation. 2005; 112: 2175-83
|
|
|
|
|
|
29) Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 989-97
|
|
|
|
|
|
30) Kapur A, Malik IS, Bagger JP, et al. The Coronary Artery Revascularization in Diabetes (CARDia) trial: Background, aim, and design. Am Heart J. 2005; 149: 13-9
|
|
|
|
|
|
31) Breeman A, Hordijk-Trion M, Lenzen M, et al. Treatment decision in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. J Thorac Cardiovasc Surg. 2006; 135: 1001-9
|
|
|
|
|
|
32) Detre K, Lombardero MS, Brooks MM, et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med. 2000; 342: 989-97
|
|
|
|
|
|
33) Gersh BJ, Frye RL. Methods of coronary revascu-larization-Things may not be as they seem. N Engl J Med. 2005; 352: 2235-7
|
|
|
|
|
|
34) Klein R, Klein BE, Moss SE, et al. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999; 117: 1487- 95
|
|
|
|
|
|
35) Klein BE, Klein R, McBride PE, et al. Cardiovas-cular disease, mortality, and retinal microvas-cular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med. 2004; 164: 1917-24
|
|
|
|
|
|
36) Henricsson M, Nilsson A, Heiji A, et al. Mortality in diabetic patients participating in an ophthalmo-logical control and screening programme. Diabet Med. 1997; 14: 576-83
|
|
|
|
|
|
37) Mittinen H, Haffner SM, Lehto S, et al. Retinop-athy predicts coronary heart disease events in NIDDM patients. Diabetes Care. 1996; 19: 1445-8
|
|
|
|
|
|
38) Faglia E, Favales F, Calia P, et al. Milan Study on Atherosclerosis and Diabetes (MiSAD). Cardiac events in 735 type 2 diabetic patients who under-went screening for unknown asymptomatic coro-nary heart disease: 5-year follow-up report from Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002; 25: 2032-6
|
|
|
|
|
|
39) Torffvit O, Lovestam-Adrian M, Agardh E, et al. Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med. 2005; 22: 723-9
|
|
|
|
|
|
40) Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004; 27: 530-7
|
|
|
|
|
|
41) Brown HB, Waugh NR, Jennings PE. Micro-angiopathy as a prognostic indicator in diabetic patients suffering from acute myocardial infraction. Scott Med J. 1992; 37: 44-6
|
|
|
|
|
|
42) Fava S, Azzopardi J, Muscat HA, et al. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care. 1993; 16: 1615-8
|
|
|
|
|
|
43) Ohno T, Ando J, Ono M, et al. The Beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy. Eur J Cardiothorac Surg. 2006; 30: 881-6
|
|
|
|
|
|
44) Ono T, Kobayashi J, Sasako Y, et al. The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol. 2002; 40: 428-36
|
|
|
|
|
|
45) Ohno T, Takamoto S, Ando J, et al. Diabetic retinopathy and coronary implantation of sirolimus-eluting stents. J Interven Cardiol. 2007; 20: 1-10
|
|
|
|
|
|
46) Breeman A, Bertrand ME, Ottervanger JP, et al. Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care. 2006; 29: 2003-11
|
|
|
|
|